388 related articles for article (PubMed ID: 27313452)
1. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
[TBL] [Abstract][Full Text] [Related]
4. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A
Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664
[TBL] [Abstract][Full Text] [Related]
5. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
Hao W; Li M; Zhang Y; Zhang C; Wang P
Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
[TBL] [Abstract][Full Text] [Related]
6. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
7. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity.
Uysal P; Uzun H
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781876
[TBL] [Abstract][Full Text] [Related]
9. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
[TBL] [Abstract][Full Text] [Related]
11. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
Boschetto P; Quintavalle S; Zeni E; Leprotti S; Potena A; Ballerin L; Papi A; Palladini G; Luisetti M; Annovazzi L; Iadarola P; De Rosa E; Fabbri LM; Mapp CE
Thorax; 2006 Dec; 61(12):1037-42. PubMed ID: 16769715
[TBL] [Abstract][Full Text] [Related]
12. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
13. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
[TBL] [Abstract][Full Text] [Related]
14. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness.
Chen C; Jian W; Gao Y; Xie Y; Song Y; Zheng J
Int J Chron Obstruct Pulmon Dis; 2016; 11():2519-2526. PubMed ID: 27785008
[TBL] [Abstract][Full Text] [Related]
15. MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population.
Bchir S; Ben Nasr H; Garrouch A; Ben Anes A; Abbassi A; Tabka Z; Chahed K
J Gene Med; 2018 Jan; 20(1):. PubMed ID: 29165854
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for FEV
Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
[TBL] [Abstract][Full Text] [Related]
17. α1,6-Fucosyltransferase (Fut8) is implicated in vulnerability to elastase-induced emphysema in mice and a possible non-invasive predictive marker for disease progression and exacerbations in chronic obstructive pulmonary disease (COPD).
Kamio K; Yoshida T; Gao C; Ishii T; Ota F; Motegi T; Kobayashi S; Fujinawa R; Ohtsubo K; Kitazume S; Angata T; Azuma A; Gemma A; Nishimura M; Betsuyaku T; Kida K; Taniguchi N
Biochem Biophys Res Commun; 2012 Jul; 424(1):112-7. PubMed ID: 22732410
[TBL] [Abstract][Full Text] [Related]
18. Airway distensibility and volume recruitment with lung inflation in COPD.
Baldi S; Dellacà R; Govoni L; Torchio R; Aliverti A; Pompilio P; Corda L; Tantucci C; Gulotta C; Brusasco V; Pellegrino R
J Appl Physiol (1985); 2010 Oct; 109(4):1019-26. PubMed ID: 20651219
[TBL] [Abstract][Full Text] [Related]
19. Relationship between expression of matrix metalloproteinase-9 and adenylyl cyclase-associated protein 1 in chronic obstructive pulmonary disease.
Xie SS; Hu F; Tan M; Duan YX; Song XL; Wang CH
J Int Med Res; 2014 Dec; 42(6):1272-84. PubMed ID: 25332229
[TBL] [Abstract][Full Text] [Related]
20. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]